期刊文献+

紫杉醇脂质体治疗非小细胞肺癌临床效果观察 被引量:5

下载PDF
导出
摘要 目的探讨紫杉醇脂质体治疗非小细胞肺癌肺癌的临床效果。方法选择我院2007年3月至2010年3月60例非小细胞肺癌患者,将上述患者随机分为两组,观察组和对照组。观察组给予紫杉醇脂质体联合顺铂化疗。对照组应用紫杉醇联合顺铂化疗。两组21d为1个周期,至少治疗2个周期。结果观察组RR和DCR分别与对照组比较,差异无统计学意义(P>0.05);观察组皮疹、肌肉痛、恶心呕吐发生率分别与对照组比较,差异有统计学意义(P<0.05)。结论紫杉醇脂质体治疗非小细胞肺癌临床效果和紫杉醇相似,但前者皮疹、恶心呕吐、肌肉痛不良反应显著低于后者。
出处 《中国医药指南》 2011年第25期62-63,共2页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献39

  • 1周卫,翁帼英,陈文忠,庄翌,傅晓阳,程光.紫杉醇脂质体在大鼠体内的组织分布[J].中国药学杂志,2005,40(18):1402-1404. 被引量:54
  • 2刘伟,李苏宜.卵巢癌化疗新进展[J].肿瘤基础与临床,2006,19(6):526-528. 被引量:19
  • 3冯威健,张红梅,赵艳杰,周蕾,曹艺,姜妮,刘巍,韩素红.紫杉醇导致过敏性休克4例的防治经验[J].临床肿瘤学杂志,2007,12(1):55-57. 被引量:13
  • 4Ghamande S, Leie S, Marchetti D, et al. Weekly paclitaxel in patients with reacurrent or persistent advanced ovarian cancer[J]. Int Gynecol Cancer,2003,13 : 142-147.
  • 5Schmitt-Sody M, Strietht S, Karanici S, et al. Neovascular-targeting therapy paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy[J]. Clin Cancer Res,2003,9(6) :2335-2341.
  • 6Lord RV,Brabender J,Gandara D,et al.Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer[J].Clin Cancer Res,2002,8(7):2286-2291.
  • 7Onn A,Correa AM,Glicrease M,et al.Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stageⅠnon-small cell lung cancer[J].Clin Cancer Res,2004,10(1):136-143.
  • 8Brattstrom D,Wester K,Bergqvist M,et al.HER-2,EGFR,COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer[J].Acta Oncol,2004,43(1):80-86.
  • 9Sugano S,Mukai K,Tsuda H,et al.Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma:an indicator of aggressiveness[J].Laryngo-scope,1992,102(8):923-927.
  • 10Prenzel N,Fischer OM,Streit S,et al.The epidermal growth fator receptor family as a central element for cellular signal transduction and diversification[J].Endocr Relat Cancer,2001,8(1):11-31.

共引文献17

同被引文献41

  • 1郭其森.非小细胞肺癌化疗研究进展[J].山东医药,2003,43(35):51-52. 被引量:6
  • 2王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:626
  • 3王建中,张长春.康莱特胶丸加同步放化疗治疗局部晚期非小细胞肺癌的临床研究[J].中华肿瘤防治杂志,2007,14(19):1502-1503. 被引量:6
  • 4KLAUBER N, PAEANGI S, FLYNN E, et al. inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2 - methoxyestradiol and taxoi [ J ] . Cancer Res, 1997, 57(1) :81 -86.
  • 5SCHMITI'-SODY M, STRIETH S, KRASNICI S, et al. Neovascular targeting therapy : paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy [ J ]. Clin Cancer Res, 2003,9(6) :2335 -2341.
  • 6TREAT J, DAMJANOV N, HUANG C, et al. Liposomal - encapsulated chemotherapy: preliminary results of a phase | study of a novel liposomal paclitaxel [ J ]. Oncology, 2001,15 (57) :44 -48.
  • 7Herhst RS,Heymach JV,Lippman SM. Lung cancer[ J]. N Eng! Med,2008,359 ( 13 ) : 1367 - 1380.
  • 8Hida T, Ogava S, Park JC, et al. Gefitinib for the treatment of non- small-cell lung cancer[ J]. Expert Rev Anticancer Ther, 2009,9 (1):17-35.
  • 9Kiyotaka Yoh,Kaoru Kubota,Ryutaro Kakinuma,Hironobu Ohmatsu,Koichi Goto,Seiji Niho,Nagahiro Saijo,Yutaka Nishiwaki.??Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy(J)Lung Cancer . 2007 (1)
  • 10Stathopoulos G P,Antoniou D,Dimitroulis J,Michalopoulou P,Bastas A,Marosis K,Stathopoulos J,Provata A,Yiamboudakis P,Veldekis D,Lolis N,Georgatou N,Toubis M,Pappas Ch,Tsoukalas G.Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO . 2010

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部